Clinical Trials
6
Active:3
Completed:2
Trial Phases
2 Phases
Phase 1:3
Phase 3:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (60.0%)Phase 3
2 (40.0%)Flutiform in Treatment of Patients With Asthma in Daily Clinical Practice.
Withdrawn
- Conditions
- Asthma
- First Posted Date
- 2016-06-23
- Last Posted Date
- 2018-11-16
- Lead Sponsor
- Mundipharma Pharmaceuticals B.V.
- Registration Number
- NCT02811315
Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant Pain
Phase 3
Completed
- Conditions
- Pain
- Interventions
- First Posted Date
- 2010-07-22
- Last Posted Date
- 2013-02-12
- Lead Sponsor
- Mundipharma Pharmaceuticals B.V.
- Target Recruit Count
- 113
- Registration Number
- NCT01167127
Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant Pain
Phase 3
Completed
- Conditions
- Pain
- First Posted Date
- 2010-07-22
- Last Posted Date
- 2013-02-12
- Lead Sponsor
- Mundipharma Pharmaceuticals B.V.
- Target Recruit Count
- 174
- Registration Number
- NCT01167699
News
No news found